Nipradilol
![]()  | |
| Names | |
|---|---|
| IUPAC name  [8-[2-hydroxy-3-(propan-2-ylamino)propoxy]-3,4-dihydro-2H-chromen-3-yl] nitrate   | |
| Identifiers | |
3D model (JSmol)   |  |
| ChemSpider | |
PubChem CID   |  |
| UNII | |
CompTox Dashboard (EPA)   |  |
  | |
  | |
| Properties | |
| C15H22N2O6 | |
| Molar mass | 326.349 g·mol−1 | 
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).   Infobox references   | |
Nipradilol is a beta blocker and nitric oxide donor.[1]
References
- ^ Inoue, K; Kei Noguchi, K; Masumoto, M; Wakakura, G (2011). "Effect of five years of treatment with nipradilol eye drops in patients with normal tension glaucoma". Clinical Ophthalmology. 5: 1211–6. doi:10.2147/OPTH.S23233. PMC 3180485. PMID 21966188.
 
| Forms | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Targets | 
  | ||||||||||||||
| NO donors (prodrugs)  | 
 
 
 
 
 
  | ||||||||||||||
| Enzyme (inhibitors)  | 
  | ||||||||||||||
| Others | 
 
  | ||||||||||||||
See also: Receptor/signaling modulators  | |||||||||||||||
 
     This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files. 
 